286 results on '"Bakkum-Gamez, Jamie"'
Search Results
2. Caprini assessment utilization and impact on patient safety in gynecologic surgery
3. Cost-effectiveness analysis of margin-controlled surgery for vulvar Paget’s disease
4. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease
5. Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
6. Detection of endometrial cancer using tampon-based collection and methylated DNA markers
7. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility
8. The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup
9. Quantifying procedural pain associated with office gynecologic tract sampling methods
10. PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer
11. Mohs surgery for female genital Paget’s disease: a prospective observational trial
12. Lost, mislabeled, and mishandled surgical and clinical pathology specimens: A systematic review of published literature.
13. When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic
14. Invasive vulvar extramammary Paget's disease in the United States
15. Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?
16. Ultrasound detection of endometrial cancer in women with postmenopausal bleeding: Systematic review and meta-analysis
17. Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer
18. Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection
19. A prospective clinical cohort study of women at increased risk for endometrial cancer
20. Disparities and interventions in the timeliness of endometrial cancer diagnosis and treatment in the United States: a scoping review protocol
21. Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer
22. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
23. Quality improvement in gynecologic oncology: Current successes and future promise
24. Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer
25. Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer
26. Cancer susceptibility gene mutations in type I and II endometrial cancer
27. Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability
28. Evidence-Based Screening Recommendations for Occult Cancers in the Setting of Newly Diagnosed Extramammary Paget Disease
29. Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy
30. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis
31. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease
32. Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer
33. Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses
34. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2
35. A matter of margins: Surgical and pathologic risk factors for recurrence in extramammary Paget's disease
36. Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer
37. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention
38. Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study
39. Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible
40. Sugammadex and urinary retention after hysterectomy: A propensity-matched cohort study.
41. In Reply
42. Prospective Implementation and Evaluation of a Decision-Tree Algorithm for Route of Hysterectomy
43. Preventing Ovarian Cancer in High-risk Women: One Surgery at a Time
44. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer
45. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion
46. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
47. Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer
48. Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms
49. Guidelines for Perioperative Care in Gynecologic/Oncology: Enhanced Recovery After Surgery (ERAS) Society Recommendations—2019 Update
50. Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal woman
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.